Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly

被引:421
作者
Foo, SS
Turner, CJ
Adams, S
Compagni, A
Aubyn, D
Kogata, N
Lindblom, P
Shani, M
Zicha, D
Adams, RH [1 ]
机构
[1] Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England
[2] Canc Res UK London Res Inst, Light Microscopy Lab, London WC2A 3PX, England
[3] Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel
关键词
D O I
10.1016/j.cell.2005.10.034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
New blood vessels are initially formed through the assembly or sprouting of endothelial cells, but the recruitment of supporting pericytes and vascular smooth muscle cells (mural cells) ensures the formation of a mature and stable vascular network. Defective mural-cell coverage is associated with the poorly organized and leaky vasculature seen in tumors or other human diseases. Here we report that mural cells require ephrin-B2, a ligand for Eph receptor tyrosine kinases, for normal association with small-diameter blood vessels (microvessels). Tissue-specific mutant mice display perinatal lethality; vascular defects in skin, lung, gastrointestinal tract, and kidney glomeruli; and abnormal migration of smooth muscle cells to lymphatic capillaries. Cultured ephrin-B2-deficient smooth muscle cells are defective in spreading, focal-adhesion formation, and polarized migration and show increased motility. Our results indicate that the role of ephrin-B2 and EphB receptors in these processes involves Crk-p130(CAS) signaling and suggest that ephrin-B2 has some cell-cell-contact-independent functions.
引用
收藏
页码:161 / 173
页数:13
相关论文
共 44 条
[1]
Angiogenesis and ophthalmic disease [J].
Adamis A.P. ;
Aiello L.P. ;
D'Amato R.A. .
Angiogenesis, 1999, 3 (1) :9-14
[2]
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[3]
Eph and ephrin signaling in mammary gland morphogenesis and cancer [J].
Andres, AC ;
Ziemiecki, A .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2003, 8 (04) :475-485
[4]
Betsholtz C, 2005, EXP SUPPL, V94, P115
[5]
Eph receptor tyrosine kinases in tumor and tumor microenvironment [J].
Brantley-Sieders, D ;
Schmidt, S ;
Parker, M ;
Chen, J .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (27) :3431-3442
[6]
Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[7]
EphrinA1-induced cytoskeletal re-organization requires FAK and p130cas [J].
Carter, N ;
Nakamoto, T ;
Hirai, H ;
Hunter, T .
NATURE CELL BIOLOGY, 2002, 4 (08) :565-573
[8]
Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold [J].
Chodniewicz, D ;
Klemke, RL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1692 (2-3) :63-76
[9]
Control of skeletal patterning by EphrinB1-EphB interactions [J].
Compagni, A ;
Logan, M ;
Klein, R ;
Adams, RH .
DEVELOPMENTAL CELL, 2003, 5 (02) :217-230
[10]
EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway [J].
Deroanne, C ;
Vouret-Craviari, V ;
Wang, BC ;
Pouysségur, J .
JOURNAL OF CELL SCIENCE, 2003, 116 (07) :1367-1376